- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
C.R. Bard gains clearance for biliary stent
Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray
Interventional equipment vendor C.R. Bard received 510(k) clearance this month from the Food and Drug Administration for its Memotherm Flexx biliary stent. The stent is used for treating malignant biliary obstructions, and will be marketed through Murray Hill, NJ-based Bards peripheral technologies division. The stent is available in diameters from 6 to 12 mm and lengths of 20 to 120 mm.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
